Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease

Ramiro Juncos, Luis Juncos, Robert P. Hebbel, Gregory M. Vercellotti, Zvonimir S Katusic, Karl A Nath

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Sickle cell disease (SCD), the most common inherited hematologic disorder in the United States and the most common single gene disorder in the world, causes substantial morbidity and mortality. The major pathobiologic processes that underlie SCD include vaso-occlusion, inflammation, procoagulant processes, hemolysis, and altered vascular reactivity. The present study examined the vasoactive response to α-adrenergic activation in a murine model of SCD. Isolated aortas from sickle mice as compared with wild-type mice exhibit heightened contractions to norepinephrine and phenylephrine; such responses were completely blocked by an α1-receptor antagonist, prazosin. Aortas from either group exhibited comparable contractile responses to potassium chloride and the thromboxane agonist U46619 and no contractile response to an α2-adrenergic receptor agonist, UK14304. We conclude that there is an exaggerated vasoconstrictive response to α1-receptor agonists in SCD. Because sickle crisis is induced by diverse forms of stress, the latter attended by increased adrenergic activity, our findings may be relevant to the occurrence of sickle crisis. We also suggest that such heightened reactivity may contribute to vaso-occlusive processes that underlie ischemic injury in SCD. Finally, our findings urge caution in the use of phenylephrine in patients with SCD.

Original languageEnglish (US)
Pages (from-to)263-266
Number of pages4
JournalJournal of Cardiovascular Pharmacology
Volume57
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Sickle Cell Anemia
Adrenergic Receptors
Aorta
Phenylephrine
Adrenergic Agents
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Adrenergic Agonists
Potassium Chloride
Prazosin
Thromboxanes
Hemolysis
Blood Vessels
Norepinephrine
Inflammation
Morbidity
Mortality
Wounds and Injuries
Genes

Keywords

  • a1-adrenergic receptors
  • phenylephrine
  • sickle cell disease
  • vascular reactivity
  • vasoconstriction

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease. / Juncos, Ramiro; Juncos, Luis; Hebbel, Robert P.; Vercellotti, Gregory M.; Katusic, Zvonimir S; Nath, Karl A.

In: Journal of Cardiovascular Pharmacology, Vol. 57, No. 2, 02.2011, p. 263-266.

Research output: Contribution to journalArticle

@article{f6a0c6fbe757463d87af870cc861b69b,
title = "Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease",
abstract = "Sickle cell disease (SCD), the most common inherited hematologic disorder in the United States and the most common single gene disorder in the world, causes substantial morbidity and mortality. The major pathobiologic processes that underlie SCD include vaso-occlusion, inflammation, procoagulant processes, hemolysis, and altered vascular reactivity. The present study examined the vasoactive response to α-adrenergic activation in a murine model of SCD. Isolated aortas from sickle mice as compared with wild-type mice exhibit heightened contractions to norepinephrine and phenylephrine; such responses were completely blocked by an α1-receptor antagonist, prazosin. Aortas from either group exhibited comparable contractile responses to potassium chloride and the thromboxane agonist U46619 and no contractile response to an α2-adrenergic receptor agonist, UK14304. We conclude that there is an exaggerated vasoconstrictive response to α1-receptor agonists in SCD. Because sickle crisis is induced by diverse forms of stress, the latter attended by increased adrenergic activity, our findings may be relevant to the occurrence of sickle crisis. We also suggest that such heightened reactivity may contribute to vaso-occlusive processes that underlie ischemic injury in SCD. Finally, our findings urge caution in the use of phenylephrine in patients with SCD.",
keywords = "a1-adrenergic receptors, phenylephrine, sickle cell disease, vascular reactivity, vasoconstriction",
author = "Ramiro Juncos and Luis Juncos and Hebbel, {Robert P.} and Vercellotti, {Gregory M.} and Katusic, {Zvonimir S} and Nath, {Karl A}",
year = "2011",
month = "2",
doi = "10.1097/FJC.0b013e318204bb34",
language = "English (US)",
volume = "57",
pages = "263--266",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease

AU - Juncos, Ramiro

AU - Juncos, Luis

AU - Hebbel, Robert P.

AU - Vercellotti, Gregory M.

AU - Katusic, Zvonimir S

AU - Nath, Karl A

PY - 2011/2

Y1 - 2011/2

N2 - Sickle cell disease (SCD), the most common inherited hematologic disorder in the United States and the most common single gene disorder in the world, causes substantial morbidity and mortality. The major pathobiologic processes that underlie SCD include vaso-occlusion, inflammation, procoagulant processes, hemolysis, and altered vascular reactivity. The present study examined the vasoactive response to α-adrenergic activation in a murine model of SCD. Isolated aortas from sickle mice as compared with wild-type mice exhibit heightened contractions to norepinephrine and phenylephrine; such responses were completely blocked by an α1-receptor antagonist, prazosin. Aortas from either group exhibited comparable contractile responses to potassium chloride and the thromboxane agonist U46619 and no contractile response to an α2-adrenergic receptor agonist, UK14304. We conclude that there is an exaggerated vasoconstrictive response to α1-receptor agonists in SCD. Because sickle crisis is induced by diverse forms of stress, the latter attended by increased adrenergic activity, our findings may be relevant to the occurrence of sickle crisis. We also suggest that such heightened reactivity may contribute to vaso-occlusive processes that underlie ischemic injury in SCD. Finally, our findings urge caution in the use of phenylephrine in patients with SCD.

AB - Sickle cell disease (SCD), the most common inherited hematologic disorder in the United States and the most common single gene disorder in the world, causes substantial morbidity and mortality. The major pathobiologic processes that underlie SCD include vaso-occlusion, inflammation, procoagulant processes, hemolysis, and altered vascular reactivity. The present study examined the vasoactive response to α-adrenergic activation in a murine model of SCD. Isolated aortas from sickle mice as compared with wild-type mice exhibit heightened contractions to norepinephrine and phenylephrine; such responses were completely blocked by an α1-receptor antagonist, prazosin. Aortas from either group exhibited comparable contractile responses to potassium chloride and the thromboxane agonist U46619 and no contractile response to an α2-adrenergic receptor agonist, UK14304. We conclude that there is an exaggerated vasoconstrictive response to α1-receptor agonists in SCD. Because sickle crisis is induced by diverse forms of stress, the latter attended by increased adrenergic activity, our findings may be relevant to the occurrence of sickle crisis. We also suggest that such heightened reactivity may contribute to vaso-occlusive processes that underlie ischemic injury in SCD. Finally, our findings urge caution in the use of phenylephrine in patients with SCD.

KW - a1-adrenergic receptors

KW - phenylephrine

KW - sickle cell disease

KW - vascular reactivity

KW - vasoconstriction

UR - http://www.scopus.com/inward/record.url?scp=78851469077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78851469077&partnerID=8YFLogxK

U2 - 10.1097/FJC.0b013e318204bb34

DO - 10.1097/FJC.0b013e318204bb34

M3 - Article

C2 - 21107280

AN - SCOPUS:78851469077

VL - 57

SP - 263

EP - 266

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 2

ER -